Pressroom

Using multiple medications with known cardiovascular adverse effects at the same time substantially increases cardiovascular risk.

There is little evidence that older adults prescribed benzodiazepines are at increased risk of developing dementia.

A new USC Schaeffer Center white paper shows how state-level cannabis regulations have weak public health parameters compared to other countries, leaving consumers vulnerable.

Analysis of cases that went through dispute resolution found the final allowed were largely anchored to the established.

USC has received $5.8 million from Gates Ventures and the American Heart Association to launch a lab aimed at diversifying clinical trials.

A new USC Schaeffer Center paper highlights tactics used by intermediaries in the pharmaceutical distribution system, including pharmacy benefit managers (PBMs) and insurers, that are costing patients, employers and the government billions for what should be inexpensive medicines.

Researchers observed a 23% drop in opioid prescriptions and a 27% increase in prescriptions for naloxone.

Populations underrepresented in clinical trials face worse health outcomes that will cost the U.S. trillions of dollars over the next three decades.

Although big data is revolutionizing healthcare, its potential has been limited by underrepresentation of vulnerable populations, including marginalized racial and socioeconomic groups that are at higher risk for poor health outcomes.

Rosalie Liccardo Pacula presented findings at the U.N. Commission on Narcotic Drugs side event.